Murine P-glycoprotein deficiency alters intestinal injury repair and blunts lipopolysaccharide-induced radioprotection

Radiation Research

Volumn 178, Issue 3, 2012, Pages 207-216

  Staley, Elizabeth M ^a,b   Yarbrough, Vanisha R ^e   Schoeb, Trenton R ^c   Daft, Joseph G ^d   Tanner, Scott M ^d   Steverson, Dennis ^d   Lorenz, Robin G ^a,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; CRYPT CELL; DESCENDING COLON; ENZYME LINKED IMMUNOSORBENT ASSAY; ILEUM; INTESTINE INJURY; JEJUNUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION INJURY; RADIATION INJURY REPAIR; RADIATION PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMALL INTESTINE; STEM CELL; WHOLE BODY RADIATION; WILD TYPE; X IRRADIATION;

ANIMALIA; MURINAE; MUS;

EID: 84866320224     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2835.1     Document Type: Article

References (46)

1. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, et al. Multidrug-resistance gene (p-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989; 86:695-8. (Pubitemid 19037807)
2. Klimecki WT, Futscher BW, Grogan TM, Dalton WS. Pglycoprotein expression and function in circulating blood cells from normal volunteers. Blood 1994; 83:2451-8. (Pubitemid 24135836)
3. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product p-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987; 84:7735-8.
4. Fromm MF. P-glycoprotein: A defense mechanism limiting oral bioavailability and cns accumulation of drugs. Int J Clin Pharmacol Ther 2000; 38:69-74. (Pubitemid 30077981)
5. Mizutani T, Masuda M, Nakai E, Furumiya K, Togawa H, Nakamura Y, et al. Genuine functions of p-glycoprotein (abcb1). Curr Drug Metab 2008; 9:167-74. (Pubitemid 351461005)
6. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81:116-24. (Pubitemid 19031328)
7. Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 1993; 85:632-9. (Pubitemid 23120508)
8. Fiedler T, Buning C, Reuter W, Pitre G, Gentz E, Schmidt HH, et al. Possible role of mdr1 two-locus genotypes for young-age onset ulcerative colitis but not crohn's disease. Eur J Clin Pharmacol 2007; 63:917-25. (Pubitemid 47387906)
9. Ho GT, Soranzo N, Nimmo ER, Tenesa A, Goldstein DB, Satsangi J. Abcb1/mdr1 gene determines susceptibility and phenotype in ulcerative colitis: Discrimination of critical variants using a genewide haplotype tagging approach. Hum Mol Genet 2006; 15:797-805. (Pubitemid 43264704)
10. Onnie CM, Fisher SA, Pattni R, Sanderson J, Forbes A, Lewis CM, et al. Associations of allelic variants of the multidrug resistance gene (abcb1 or mdr1) and inflammatory bowel disease and their effects on disease behavior: A case-control and metaanalysis study. Inflamm Bowel Dis 2006; 12:263-71.
11. Potocnik U, Ferkolj I, Glavac D, Dean M. Polymorphisms in multidrug resistance 1 (mdr1) gene are associated with refractory crohn disease and ulcerative colitis. Genes Immun 2004; 5:530-9. (Pubitemid 39529969)
12. Staley EM, Schoeb TR, Lorenz RG. Differential susceptibility of p-glycoprotein deficient mice to colitis induction by environmental insults. Inflamm Bowel Dis 2009; 15:684-96.
13. Thevenod F, Friedmann JM, Katsen AD, Hauser IA. Up-regulation of multidrug resistance p-glycoprotein via nuclear factor-kappab activation protects kidney proximal tubule cells from cadmiumand reactive oxygen species-induced apoptosis. J Biol Chem 2000; 275:1887-96. (Pubitemid 30060813)
14. Pallis M, Turzanski J, Higashi Y, Russell N. P-glycoprotein in acute myeloid leukaemia: Therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype. Leuk Lymphoma 2002; 43:1221-8. (Pubitemid 34537966)
15. Bjerknes M, Cheng H. The stem-cell zone of the small intestinal epithelium. I. Evidence from paneth cells in the adult mouse. Am J Anat 1981; 160:51-63. (Pubitemid 11096907)
16. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 1974; 141:537-61.
17. Potten CS, Loeffler M. Stem cells: Attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990; 110:1001-20. (Pubitemid 120009472)
18. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
19. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: The importance of apoptosis. J Cell Sci 1994; 107 (Pt 12):3569-77.
20. Potten CS. A comprehensive study of the radiobiological response of the murine (bdf1) small intestine. Int J Radiat Biol 1990; 58:925-73.
21. Potten CS, Loeffler M. A comprehensive model of the crypts of the small intestine of the mouse provides insight into the mechanisms of cell migration and the proliferation hierarchy. J Theor Biol 1987; 127:381-91.
22. Houchen CW, Stenson WF, Cohn SM. Disruption of cyclooxygenase-1 gene results in an impaired response to radiation injury. Am J Physiol Gastrointest Liver Physiol 2000; 279:G858-65.
23. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al. Cyclooxygenase in biology and disease. Faseb J 1998; 12:1063-73. (Pubitemid 28418937)
24. Newberry RD, McDonough JS, Stenson WF, Lorenz RG. Spontaneous and continuous cyclooxygenase-2-dependent prostaglandin e2 production by stromal cells in the murine small intestine lamina propria: Directing the tone of the intestinal immune response. J Immunol 2001; 166:4465-72. (Pubitemid 32233730)
25. Newberry RD, Stenson WF, Lorenz RG. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat Med 1999; 5:900-6. (Pubitemid 29372416)
26. Wallace JL, Ma L. Inflammatory mediators in gastrointestinal defense and injury. Exp Biol Med 2001; 226:1003-15.
27. Riehl TE, Newberry RD, Lorenz RG, Stenson WF. Tnfr1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine. Am J Physiol Gastrointest Liver Physiol 2004; 286:G166-73. (Pubitemid 38055850)
28. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998; 161:5733-44. (Pubitemid 28519142)
29. Cohn SM, Lieberman MW. The use of antibodies to 5-bromo-20-deoxyuridine for the isolation of DNA sequences containing excision-repair sites. J Biol Chem 1984; 259:12456-62. (Pubitemid 15204823)
30. Chomczynski P, Sacchi N. Single-step method of rna isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9. (Pubitemid 17064313)
31. Booth D, Potten CS. Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr 2001; 16-20.
32. Mouly S, Paine MF. P-glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 2003; 20:1595-9. (Pubitemid 37268274)
33. Moriguchi J, Kato R, Nakagawa M, Hirotani Y, Ijiri Y, Tanaka K. Effects of lipopolysaccharide on intestinal p-glycoprotein expression and activity. Eur J Pharmacol 2007; 565:220-4. (Pubitemid 46782777)
34. Patel VA, Dunn MJ, Sorokin A. Regulation of mdr-1 (pglycoprotein) by cyclooxygenase-2. J Biol Chem 2002; 277:38915-20.
35. Bass H, Mosmann T, Strober S. Evidence for mouse th1-and th2-like helper t cells in vivo. Selective reduction of th1-like cells after total lymphoid irradiation. J Exp Med 1989; 170:1495-511. (Pubitemid 19284554)
36. Hancock SL, Chung RT, Cox RS, Kallman RF. Interleukin 1 beta initially sensitizes and subsequently protects murine intestinal stem cells exposed to photon radiation. Cancer Res 1991; 51:2280-5.
37. Johnke RM, Smith ES, Cariveau MJ, Evans MJ, Kilburn JM, Bakken NT, et al. Radioprotection of murine gastrointestinal epithelium by interleukin-1alpha involves down-regulation of the apoptotic response. Anticancer Res 2008; 28:3601-7.
38. Wu SG, Miyamoto T. Radioprotection of the intestinal crypts of mice by recombinant human interleukin-1 alpha. Radiat Res 1990; 123:112-5. (Pubitemid 20218102)
39. Bharhani MS, Borojevic R, Basak S, Ho E, Zhou P, Croitoru K. Il-10 protects mouse intestinal epithelial cells from fas-induced apoptosis via modulating fas expression and altering caspase-8 and flip expression. Am J Physiol Gastrointest Liver Physiol 2006; 291:G820-9. (Pubitemid 44772008)
40. Resta-Lenert S, Smitham J, Barrett KE. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/-mice. Am J Physiol Gastrointest Liver Physiol 2005; 289:G153-62. (Pubitemid 40944234)
41. Cohn SM, Schloemann S, Tessner T, Seibert K, Stenson WF. Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase-1. J Clin Invest 1997; 99:1367-79. (Pubitemid 27142775)
42. Riehl T, Cohn S, Tessner T, Schloemann S, Stenson WF. Lipopolysaccharide is radioprotective in the mouse intestine through a prostaglandin-mediated mechanism. Gastroenterology 2000; 118:1106-16. (Pubitemid 30346987)
43. Hinterleitner TA, Saada JI, Berschneider HM, Powell DW, Valentich JD. Il-1 stimulates intestinal myofibroblast cox gene expression and augments activation of cl-secretion in t84 cells. Am J Physiol 1996; 271:C1262-8.
44. Glaccum MB, Stocking KL, Charrier K, Smith JL, Willis CR, Maliszewski C, et al. Phenotypic and functional characterization of mice that lack the type i receptor for il-1. J Immunol 1997; 159:3364-71. (Pubitemid 127482095)
45. Arend WP, Malyak M, Smith MF, Jr., Whisenand TD, Slack JL, Sims JE, et al. Binding of il-1 alpha, il-1 beta, and il-1 receptor antagonist by soluble il-1 receptors and levels of soluble il-1 receptors in synovial fluids. J Immunol 1994; 153:4766-74. (Pubitemid 24346872)
46. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, et al. Interleukin 1 signaling occurs exclusively via the type i receptor. Proc Natl Acad Sci USA 1993; 90:6155-9. (Pubitemid 23191473)